The increase of LEP in the lungs and serum is associated with potentially worsening or hastening the development of lung diseases, including acute lung injury (ALI), acute respiratory distress syndrome, chronic obstructive pulmonary disease (COPD), airway remodeling associated with asthma, and lung cancer [21]. This evidence concerns the gene LEP and acute respiratory distress syndrome.